Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 13 studies | 20% ± 5% | |
peripheral blood | 13 studies | 23% ± 8% | |
brain | 13 studies | 35% ± 18% | |
eye | 8 studies | 26% ± 9% | |
liver | 5 studies | 27% ± 13% | |
bone marrow | 4 studies | 19% ± 4% | |
kidney | 4 studies | 22% ± 4% | |
adipose | 4 studies | 26% ± 3% | |
pancreas | 3 studies | 36% ± 16% | |
heart | 3 studies | 24% ± 6% | |
intestine | 3 studies | 24% ± 6% | |
lymph node | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2346.45 | 1445 / 1445 | 100% | 16.86 | 183 / 183 |
lung | 100% | 2581.45 | 578 / 578 | 99% | 9.70 | 1149 / 1155 |
brain | 99% | 2249.40 | 2621 / 2642 | 100% | 10.81 | 703 / 705 |
breast | 100% | 3014.71 | 459 / 459 | 99% | 15.68 | 1104 / 1118 |
thymus | 100% | 3623.13 | 653 / 653 | 98% | 11.75 | 595 / 605 |
ovary | 100% | 2693.43 | 180 / 180 | 98% | 6.99 | 420 / 430 |
pancreas | 99% | 1317.89 | 325 / 328 | 98% | 8.51 | 175 / 178 |
stomach | 100% | 1764.17 | 359 / 359 | 97% | 11.03 | 278 / 286 |
prostate | 100% | 2268.08 | 245 / 245 | 97% | 10.50 | 487 / 502 |
kidney | 100% | 1566.67 | 89 / 89 | 97% | 10.19 | 873 / 901 |
intestine | 100% | 2407.92 | 966 / 966 | 97% | 9.10 | 510 / 527 |
uterus | 100% | 3029.39 | 170 / 170 | 97% | 9.31 | 444 / 459 |
adrenal gland | 100% | 1911.43 | 258 / 258 | 97% | 8.31 | 222 / 230 |
bladder | 100% | 2487.33 | 21 / 21 | 95% | 7.51 | 479 / 504 |
skin | 100% | 3327.68 | 1809 / 1809 | 91% | 10.40 | 431 / 472 |
liver | 99% | 966.59 | 223 / 226 | 79% | 4.21 | 322 / 406 |
blood vessel | 100% | 2909.44 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1964.29 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 2768.98 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1517.06 | 802 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 10.57 | 44 / 45 |
heart | 95% | 1360.39 | 820 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 9.50 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 68% | 4.10 | 54 / 80 |
peripheral blood | 44% | 1227.83 | 412 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070898 | Biological process | RNA polymerase III preinitiation complex assembly |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000126 | Cellular component | transcription factor TFIIIB complex |
GO_0005515 | Molecular function | protein binding |
GO_0001156 | Molecular function | TFIIIC-class transcription factor complex binding |
Gene name | BDP1 |
Protein name | Transcription factor TFIIIB component B'' homolog B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB (Transcription factor TFIIIB component B'' homolog) Transcription factor TFIIIB component B'' homolog (Transcription factor IIIB 150) (TFIIIB150) (Transcription factor-like nuclear regulator) BDP1 protein |
Synonyms | KIAA1241 KIAA1689 TFNR |
Description | FUNCTION: General activator of RNA polymerase III transcription. Requires for transcription from all three types of polymerase III promoters. Requires for transcription of genes with internal promoter elements and with promoter elements upstream of the initiation site. . |
Accessions | ENST00000616093.1 A6H8Y1 ENST00000617085.4 [A6H8Y1-1] A0A0G2JN16 ENST00000613844.2 ENST00000611966.3 H0YCV8 A0A0A0MRX7 ENST00000628099.2 H7C5U4 ENST00000358731.9 [A6H8Y1-1] ENST00000525844.1 A0A0G2JNU3 ENST00000612125.4 B1WB49 ENST00000614425.1 ENST00000627715.1 ENST00000514903.7 |